DELRE, PIETRO
 Distribuzione geografica
Continente #
NA - Nord America 128
EU - Europa 62
AS - Asia 58
OC - Oceania 1
Totale 249
Nazione #
US - Stati Uniti d'America 128
CN - Cina 28
SG - Singapore 28
IT - Italia 18
SE - Svezia 15
DE - Germania 11
GB - Regno Unito 5
RU - Federazione Russa 4
CZ - Repubblica Ceca 3
FI - Finlandia 2
FR - Francia 2
IN - India 2
AT - Austria 1
AU - Australia 1
UA - Ucraina 1
Totale 249
Città #
Chandler 22
Singapore 18
Nyköping 14
Ashburn 10
Fairfield 8
New York 8
Bari 7
Boardman 5
Munich 5
Wilmington 5
Woodbridge 5
Houston 4
Beijing 3
Lawrence 3
Los Angeles 3
Roxbury 3
Shanghai 3
Triggiano 3
Ann Arbor 2
Helsinki 2
Inglewood 2
London 2
Molfetta 2
Olomouc 2
Seattle 2
Wuhan 2
Augusta 1
Brno 1
Brooklyn 1
Cambridge 1
Canberra 1
Dalian 1
Guangzhou 1
Hanover 1
Heze 1
Islington 1
Kansas City 1
Marseille 1
Messina 1
Monmouth Junction 1
Paris 1
Qingdao 1
Quanzhou 1
Redwood City 1
San Mateo 1
Sannicandro di Bari 1
Shenzhen 1
Vienna 1
Washington 1
Zibo 1
Totale 169
Nome #
Exploring the role of elongation Factor-Like 1 (EFL1) in Shwachman-Diamond syndrome through molecular dynamics 72
Cannabinoid Receptor Subtype 2 (CB2R) in a Multitarget Approach: Perspective of an Innovative Strategy in Cancer and Neurodegeneration 50
Radiosynthesis and characterization of [18F]BS224: a next-generation TSPO PET ligand insensitive to the rs6971 polymorphism 21
DeLA-Drug: A Deep Learning Algorithm for Automated Design of Druglike Analogues 21
Bioisosteric replacement based on 1,2,4-oxadiazoles in the discovery of 1H-indazole-bearing neuroprotective MAO B inhibitors 14
Development of N-(1-Adamantyl)benzamides as Novel Anti-Inflammatory Multitarget Agents Acting as Dual Modulators of the Cannabinoid CB2 Receptor and Fatty Acid Amide Hydrolase 14
hERG stereoselective modulation by mexiletine‐derived ureas: Molecular docking study, synthesis, and biological evaluation 13
Endocannabinoid Degradation Enzyme Inhibitors as Potential Antipsychotics: A Medicinal Chemistry Perspective 11
N-adamantyl-anthranil amide derivatives: New selective ligands for the cannabinoid receptor subtype 2 (CB2R) 11
A conformational rearrangement of the SARS-CoV-2 host protein sigma-1 is required for antiviral activity: insights from a combined in-silico/in-vitro approach 9
Controlling the Binding Efficiency of Surface Confined Antibodies through the Design of Mixed Self-Assembled Monolayers 9
AMALPHI: A Machine Learning Platform for Predicting Drug-Induced PhospholIpidosis 9
Development of Fluorescent 4-[4-(3H-Spiro[isobenzofuran-1,4′-piperidin]-1′-yl)butyl]indolyl Derivatives as High-Affinity Probes to Enable the Study of σ Receptors via Fluorescence-Based Techniques 9
Structure-based design of multitargeting ChEs-MAO B inhibitors based on phenyl ring bioisosteres: AChE/BChE selectivity switch and drug-like characterization 8
Development of Riluzole Analogs with Improved Use-Dependent Inhibition of Skeletal Muscle Sodium Channels 7
N‑Adamantyl-1-alkyl-4-oxo-1,4-dihydroquinoline-3-carboxamide Derivatives as Fluorescent Probes to Detect Microglia Activation through the Imaging of Cannabinoid Receptor Subtype 2 (CB2R) 6
ALPACA: A machine Learning Platform for Affinity and selectivity profiling of CAnnabinoids receptors modulators 6
Structure-Based Prediction of hERG-Related Cardiotoxicity: A Benchmark Study 4
DeLA-DrugSelf: Empowering multi-objective de novo design through SELFIES molecular representation 1
Totale 295
Categoria #
all - tutte 2.249
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.249


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202020 0 0 0 0 0 0 0 6 6 3 3 2
2020/202129 1 3 0 11 1 2 0 2 0 3 4 2
2021/202220 0 0 0 1 0 2 0 2 2 1 3 9
2022/202361 5 9 2 6 5 9 1 9 7 0 6 2
2023/2024106 2 8 7 10 9 12 6 0 1 11 4 36
2024/202559 35 3 21 0 0 0 0 0 0 0 0 0
Totale 295